
Health Tech Must Keep Pace With the Science That Drives It
The industry is pulled between red-hot hype and lukewarm implementation. Are we ready to bridge the gap?
The Healthcare Analytics News™ team just finished recording its first Peer Exchange (of many), and my mind is still aflutter with the momentous ideas of our all-star panel. I’m trying to make sense of the wealth of insights that burst forth during the filming, and I’m left with a lingering notion: Healthcare moves faster every day, but challenges remain, and they’re preventing us from keeping pace with our own advancements.
Or are these challenges opportunities? Well, that depends on who you ask.
In one of my favorite segments of the talk (footage will roll out in early August, so keep an eye on
Fellow panelist and rheumatologist
But
His assertion begged a question from Nayyer. “John, how many kids do you have?” she asked.
“Three,” Nosta said.
“Three kids. Would you like them to be delivered by [IBM's] Watson?”
“No. Not Watson. But maybe Watson 3.0,” he said.
Here, Nosta is thinking about the promise of health tech, not its pitfalls. And why shouldn’t he? The fact remains that both our collective human brainpower and our finest technological advancements have fallen short of the task when it comes to untangling the hordes of data that could be making—or helping clinicians make­­—better decisions. And as time marches on, our brains are unlikely to muster some previously unknown power to process big data. But as Nosta alluded, with the right investments and follow-through, tech could make it happen.
Surely we can agree that the tools of health tech are promising, but our response to them has been tedious. We still
There’s hope, though. If medicine is changing faster than ever and continues on that trend of exponential growth, then the advancements of the last 20 years might seem like a snail’s pace compared with the advancements of the next 20. And the advancements of the 20 after that? And then another 20, and another, and another 20 still? Well, that places us in the year 2118—another hundred years. It might seem unrealistic today, but with the right advancements, many of us alive now could still be around by then. Here’s another prediction, but not as bold this time: In 2118, the clinic will look very, very different.
Remember hand writing admission orders?
— Mark Reid, MD (@medicalaxioms)
Remember IV heparin and PO warfarin for a new DVT?
— Mark Reid, MD (@medicalaxioms)
Remember digoxin loading for rapid atrial fibrillation?
— Mark Reid, MD (@medicalaxioms)
It feels good to know that medicine is self-correcting and pivots in response to new information. But some responses to Reid’s tweets from fellow clinicians unveiled a critical weakness that’s been precluding healthcare from reaching its full potential: The practices of yore for some hospitals are the practices du jour for others.
In my hospital we still do it 🙈
— Wilma (@ERNurseWilma)
Okay, wait. My old hospital still does this. What’s the current EBP?
— Nurse Needs Coffee (@NrsNeedsCoffee)
I did this today
— Kris (@k_d85)
While variables like location, funding, leadership, reputation, patient demographics, and more might always play into a hospital’s ability to keep up with the Joneses, a lack of information sharing from “have” hospitals to “have-not” hospitals is inexcusable and benefits no one.
Even if the haves were sharing data with the have-nots, would they have the data-refining tech to draw meaning from it? It all comes back to the question: Can healthcare keep pace with the science that drives it?
Well, I suppose that it all depends on how much we’re willing to invest and place our trust in the tools of health tech.
>>> Get the best insights in healthcare analytics
The first Healthcare Analytics News™ Peer Exchange, titled “Can Outside Disruption Save Healthcare?” will be available for viewing in early August. In the meantime, take a minute to get to know our panel.
Kevin Campbell, MD, FACC, is a Duke-trained cardiologist, CEO of PaceMate, an on-air medical expert for local and national TV news, and a member of our editorial advisory board.
John Nosta is president and founder of NostaLab, faculty member of Singularity University, member of the Google Health Advisory Board, a member of MYOS Corporation’s board of directors, senior editor and editorial board member for Lifestyle Medicine Journal, and a contributor for Forbes.
Geeta Nayyar, MD, MBA, is is a nationally recognized leader in healthcare information technology. She has been named one of the "Top 26 smartest people in Health IT" by Becker's Report. She is a noted social media expert and blogger for the Huffington Post. Med City News recognized her as one of the "Top 12 Powerful Women Voices in Healthcare Innovation and on Twitter." She is the former CMIO for AT&T and served on the HIMSS Board of Directors. Dr. Nayyar currently serves as the Chief Healthcare & Innovation Officer for Femwell Group Health, Inc., one of the largest management services organizations in the state of Florida. She is a Rheumatologist and serves on the medical school faculty at both Florida International University and George Washington University.
Related

















































